These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26358268)

  • 41. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vivo activity of ursolic and oleanolic acids during the acute phase of Trypanosoma cruzi infection.
    da Silva Ferreira D; Esperandim VR; Toldo MP; Kuehn CC; do Prado Júnior JC; Cunha WR; e Silva ML; de Albuquerque S
    Exp Parasitol; 2013 Aug; 134(4):455-9. PubMed ID: 23648663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection.
    De Souza AP; Tanowitz HB; Chandra M; Shtutin V; Weiss LM; Morris SA; Factor SM; Huang H; Wittner M; Shirani J; Jelicks LA
    Parasitol Res; 2004 Apr; 92(6):496-501. PubMed ID: 14999469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
    Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
    Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection.
    Rodrigues WF; Miguel CB; Chica JE; Napimoga MH
    Mem Inst Oswaldo Cruz; 2010 Mar; 105(2):137-43. PubMed ID: 20428671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
    Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.
    Vasconcelos JF; Souza BS; Lins TF; Garcia LM; Kaneto CM; Sampaio GP; de Alcântara AC; Meira CS; Macambira SG; Ribeiro-dos-Santos R; Soares MB
    FASEB J; 2013 Dec; 27(12):4691-702. PubMed ID: 23964077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
    Rowland E; Luo H; McCormick T
    J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Purinergic enzymatic activities in lymphocytes and cardiomyocytes of mice acutely infected by Trypanosoma cruzi modulating the inflammatory responses.
    do Carmo GM; Doleski PH; de Sá MF; Grando TH; Bottari NB; Leal DB; Gressler LT; Henker LC; Mendes RE; Monteiro SG; Da Silva AS
    Exp Parasitol; 2017 Apr; 175():44-50. PubMed ID: 28167210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.
    Waghabi MC; de Souza EM; de Oliveira GM; Keramidas M; Feige JJ; Araújo-Jorge TC; Bailly S
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4694-701. PubMed ID: 19738024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelin-1 receptors play a minor role in the protection against acute Trypanosoma cruzi infection in mice.
    Roffê E; Souza AL; Machado PP; Barcelos LS; Romanha AJ; Mariano FS; Silva JS; Machado CR; Tanowitz HB; Teixeira MM
    Braz J Med Biol Res; 2007 Mar; 40(3):391-9. PubMed ID: 17334537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasoactive-intestinal-peptide- and substance-P-immunoreactive nerve fibres in the myenteric plexus of mouse colon during the chronic phase of Trypanosoma cruzi infection.
    Maifrino LB; Liberti EA; de Souza RR
    Ann Trop Med Parasitol; 1999 Jan; 93(1):49-56. PubMed ID: 10492671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
    Souza-Silva TG; Vilas-Boas DF; Gonçalves-Santos E; Mazzeti AL; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Life Sci; 2020 Sep; 257():118067. PubMed ID: 32652140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schistosoma mansoni co-infection modulates Chagas disease development but does not impair the effect of benznidazole-based chemotherapy.
    Lozano KJG; Gonçalves Santos E; Vilas Boas DF; Oliveira RRG; Diniz LF; Benedetti MD; Carneiro CM; C Bandeira L; Faria G; Gonçalves RV; Novaes RD; Caldas S; Caldas IS
    Int Immunopharmacol; 2024 Feb; 128():111467. PubMed ID: 38211479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoactive Intestinal Peptide Ameliorates Acute Myocarditis and Atherosclerosis by Regulating Inflammatory and Autoimmune Responses.
    Benitez R; Delgado-Maroto V; Caro M; Forte-Lago I; Duran-Prado M; O'Valle F; Lichtman AH; Gonzalez-Rey E; Delgado M
    J Immunol; 2018 Jun; 200(11):3697-3710. PubMed ID: 29669783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different treatment schemes and dynamizations of Trypanosoma cruzi biotherapies: what information do they transfer to the organism in infected mice?
    Ferraz FN; da Veiga FK; Aleixo DL; Spack Júnior M; de Araújo SM
    Homeopathy; 2016 Nov; 105(4):327-337. PubMed ID: 27914572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice.
    Souza AP; Jelicks LA; Tanowitz HB; Olivieri BP; Medeiros MM; Oliveira GM; Pires AR; Santos AM; Araújo-Jorge TC
    Mem Inst Oswaldo Cruz; 2010 Sep; 105(6):746-51. PubMed ID: 20944987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trypanosoma cruzi blood trypomastigotes induce intense skeletal and cardiac muscle damage and Th1/ Th2 immune response in the acute phase of mice infected by the oral route.
    Dehesa-Rodríguez G; Martínez I; Bastida-Jaime C; Espinoza B
    Acta Trop; 2022 Oct; 234():106605. PubMed ID: 35820470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.